| p-value | ||
---|---|---|---|
Clinical parameter | TIL subtype | ITF | TC |
Tumor grade | TILs | 0.047a | 0.047a |
CD3 | 0.0407a | Â | |
cT stadium (pre-NACT) | TILs | Â | 0.004d |
CD3 | Â | 0.004d | |
CD4 | Â | 0.0118b | |
ypT stadium (post-NACT) | TILs | 0.0069c | 0.0014c |
CD3 | 0.0010c | 0.0069c | |
CD4 | 0.0014c | Â | |
CD8 | 0.0197c | Â | |
CD20 | 0.0151c | Â | |
IS CD3/CD8 | 0.0254c | ||
IS CD3/CD20 | 0.0144c | ||
clinical response | TILs | Â | 0.0204b |
CD3 | Â | 0.0235b | |
histological regression grade | TILs | Â | 0.0007c |
CD3 | 0.0308c | 0.0002c | |
CD4 | 0.037c | Â | |
CD8 | 0.0308c | 0.0008c | |
CD20 | 0.023c | 0.0196c | |
IS CD3/CD8 | 0.0093c | ||
IS CD3/CD20 | 0.0481c | ||
DTC presence post-NACT | CD4 | Â | 0.0296c |